Striatal output markers do not alter in response to circling behaviour in 6-OHDA lesioned rats produced by acute or chronic administration of the monoamine uptake inhibitor BTS 74 398

Journal of Neural Transmission

Volumn 115, Issue 3, 2008, Pages 423-429

  Lane, E L ^a,c   Cheetham, S ^b   Jenner, P ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b RenaSci Ltd   (United Kingdom)

^c CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

6 hydroxydopamine; Monoamine uptake inhibition; Motor behaviour; Preproenkephalin A; Preproenkephalin B; Preprotachykinin

Indexed keywords

BIOLOGICAL MARKER; BTS 74398; LEVODOPA; MESSENGER RNA; NEUROPEPTIDE; OXIDOPAMINE; PALMITOYL PROTEIN THIOESTERASE; PREPROENKEPHALIN; PRODYNORPHIN; PROTEIN INHIBITOR; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ANALYSIS OF VARIANCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BRAIN DAMAGE; CIRCLING BEHAVIOR; CONTROLLED STUDY; HEMISPHERE; LOCOMOTION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SENSITIZATION; STRIATE CORTEX;

ADRENERGIC AGENTS; ANIMALS; ANTIPARKINSON AGENTS; BEHAVIOR, ANIMAL; CHLOROBENZENES; CORPUS STRIATUM; CYCLOBUTANES; DYNORPHINS; ENKEPHALINS; GENE EXPRESSION; IN SITU HYBRIDIZATION; LEVODOPA; MALE; MOTOR ACTIVITY; OXIDOPAMINE; PARKINSONIAN DISORDERS; RATS; RATS, WISTAR; RNA, MESSENGER; SUBSTANCE P; TIME;

EID: 40949103943     PISSN: 03009564     EISSN: 14351463     Source Type: Journal    
DOI: 10.1007/s00702-007-0854-x     Document Type: Article

References (41)

1. M Andersson A Hilbertson MA Cenci 1999 Striatal fosB expression is causally linked with L-Dopa-induced abnormal involuntary movements and the associated upregulation of striatal prodynorphin mRNA in a rat model of Parkinson's disease Neurobiol Dis 6 461 474
2. M Bara-Jiminez T Dimitrova A Sherzai A Favit M Mouradian TN Chase 2004 Effects of monoamine reuptake inhibitor NS 2330 in advanced Parkinson's disease Mov Dis 19 1183 1186
3. K Campbell K Wictorin A Bjorklund 1992 Differential regulation of neuropeptide mRNA expression in intrastriatal striatal transplants by host dopaminergic afferents Proc Natl Acad Sci USA 89 10489 10493
4. RJ Carey 1991 Chronic L-dopa treatment in the unilateral 6-OHDA rat: evidence for behavioral sensitization and biochemical tolerance Brain Res 568 205 214
5. A Carta S Fenu M Morelli 2001 Alterations in GAD67, dynorphin and enkephalin mRNA in striatal output neurons following priming in the 6-OHDA model of Parkinson's disease Neurol Sci 22 59 60
6. MA Cenci CS Lee A Bjorklund 1998 L-DOPA-induced dyskinesia in the rat is associated with striatal overexpression of prodynorphin- and glutamic acid decarboxylase mRNA Eur J Neurosci 10 2694 2706
7. SL Collins PM Kunko B Ladenheim JL Cadet FI Carroll S Izenwasser 2002 Chronic cocaine increases kappa-opioid receptor density: lack of effect by selective dopamine uptake inhibitors Synapse 45 153 158
8. M Dziedzicka-Wasylewska D Dlaboga K Pierzchala-Koziec Z Rogoz 2002 Effect of tianeptine and fluoxetine on the levels of Met-enkephalin and mRNA encoding proenkephalin in the rat J Physiol Pharmacol 53 117 125
9. TM Engber Z Susel S Kuo CR Gerfen TN Chase 1991 Levodopa replacement therapy alters enzyme activities in striatum and neuropeptide content in striatal output regions of 6-hydroxydopamine lesioned rats Brain Res 552 113 118
10. F Fornai AB di Poggio A Pellegrini S Ruggieri A Paparelli 2007 Noradrenaline in Parkinson's disease: from disease progression to current therapeutics Curr Med Chem 14 2330 2334
11. EJ Frackiewicz SS Jhee TM Shiovitz J Webster C Topham RC Dockens D Whigan DE Salazaar NR Cutler 2002 Brasofensine treatment for Parkinson's disease in combination with levodopa/carbidopa Ann Pharmacother 36 225 230
12. CR Gerfen WS Young III 1988 Distribution of striatonigral and striatopallidal peptidergic neurons in both patch and matrix compartments: an in situ hybridization histochemistry and fluorescent retrograde tracing study Brain Res 460 161 167
13. CR Gerfen JF McGinty WS Young III 1991 Dopamine differentially regulates dynorphin, substance P, and enkephalin expression in striatal neurons: in situ hybridization histochemical analysis J Neurosci 11 1016 1031
14. MJ Hansard LA Smith MJ Jackson S Cheetham P Jenner 2002 Dopamine but not norepinephrine of serotonin reuptake inhibition reverses motor deficits in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated primates J Pharm Exp Ther 303 952 958
15. MJ Hansard LA Smith MJ Jackson S Cheetham P Jenner 2004 The monoamine reuptake inhibitor BTS 74398 fails to evoke established dyskinesia but does not synergise with levodopa in MPTP-treated primates Mov Disord 19 15 21
16. RA Hauser L Salin N Juhel VL Konyago the NS 2330 Monotherapy PD Study Group 2007 Randomized trial of the triple monoamine reuptake inhibitor NS 2330 (tesofensine) in early Parkinson's disease Mov Dis 22 359 365
17. B Henry AR Crossman JM Brotchie 1998 Characterization of enhanced behavioral responses to L-DOPA following repeated administration in the 6-hydroxydopamine-lesioned rat model of Parkinson's disease Exp Neurol 151 334 342
18. B Henry AR Crossman JM Brotchie 1999 Effect of repeated L-DOPA, bromocriptine, or lisuride administration on preproenkephalin-A and preproenkephalin-B mRNA levels in the striatum of the 6-hydroxydopamine-lesioned rat Exp Neurol 155 204 220
19. B Henry S Duty SH Fox AR Crossman JM Brotchie 2003 Increased striatal pre-proenkephalin B expression is associated with dyskinesia in Parkinson's disease Exp Neurol 183 458 468
20. MT Herrero SJ Augood EC Hirsch F Javoy-Agid MR Luquin Y Agid JA Obeso PC Emson 1995 Effects of L-DOPA on preproenkephalin and preprotachykinin gene expression in the MPTP-treated monkey striatum Neuroscience 68 1189 1198
21. YL Hurd M Herkenham 1992 Influence of a single injection of cocaine, amphetamine or GBR 12909 on mRNA expression of striatal neuropeptides Brain Res Mol Brain Res 16 97 104
22. J Jolkkonen P Jenner CD Marsden 1995 L-DOPA reverses altered gene expression of substance P but not enkephalin in the caudate-putamen of common marmosets treated with MPTP Brain Res Mol Brain Res 32 297 307
23. KM Koochesfahani R Fuente-Fernandez V Sossi M Schulzer LN Yatham TJ Ruth S Blinder A Stoessl 2006 Oral methylphenidate fails to elicit significant changes in extracellular putaminal dopamine levels in Parkinson's disease patients: positrol emission tomographic studies Mov Disord 21 970 975
24. EL Lane SC Cheetham P Jenner 2005 Repeated administration of the monoamine reuptake inhibitor BTS 74 398 induces ipsilateral circling in the 6-hydroxydopamine lesioned rat without sensitising motor behaviours Eur J Neurosci 21 179 186
25. M Lundblad M Andersson C Winkler D Kirik N Wierup MA Cenci 2002 Pharmacological validation of behavioural measures of akinesia and dyskinesia in a rat model of Parkinson's disease Eur J Neurosci 15 120 132
26. A Mura M Mintz J Feldon 2002 Behavioral and anatomical effects of long-term L-dihydroxyphenylalanine (L-DOPA) administration in rats with unilateral lesions of the nigrostriatal system Exp Neurol 177 252 264
27. JA Obeso F Grandas J Vaamonde MR Luquin J Artieda G Lera ME Rodriguez JM Martinez-Lage 1989 Motor complications associated with chronic levodopa therapy in Parkinson's disease Neurology 39 11 19
28. G Paxinos C Watson 1987 The rat brain in stereotaxic coordinates Academic Press New York
29. RK Pearce LA Smith MJ Jackson T Banerji J Scheel-Kruger P Jenner 2002 The monoamine reuptake blocker brasofensine reverses akinesia without dyskinesia in MPTP-treated and levodopa-primed common marmosets Mov Disord 17 877 886
30. P Ravenscroft S Chalon JM Brotchie AR Crossman 2004 Ropinirole versus L-DOPA effects on striatal opioid peptide precursors in a rodent model of Parkinson's disease: implications for dyskinesia Exp Neurol 185 36 46
31. P Romualdi C D'Addario S Ferri BM Cox S Izenwasser 2001 Chronic GBR 12909 administration differentially alters prodynorphin gene expression compared to cocaine Eur J Pharmacol 413 207 212
32. P Salin G Dziewczapolski OS Gershanik A Nieoullon R Raisman-Vozari 1997 Differential regional effects of long-term L-DOPA treatment on preproenkephalin and preprotachykinin gene expression in the striatum of 6-hydroxydopamine- lesioned rat Brain Res Mol Brain Res 47 311 321
33. SP Sivam 1996 Dopaminergic regulation of striatonigral tachykinin and dynorphin gene expression: a study with the dopamine uptake inhibitor GBR-12909 Brain Res Mol Brain Res 35 197 210
34. SP Sivam GR Breese JE Krause TC Napier RA Mueller JS Hong 1987 Neonatal and adult 6-hydroxydopamine-induced lesions differentially alter tachykinin and enkephalin gene expression J Neurochem 49 1623 1633
35. JA Smith FM Leslie RS Broide SE Loughlin 1993 Long-term changes in striatal opioid systems after 6-hydroxydopamine lesion of rat substantia nigra Neuroscience 55 935 951
36. M St Hilaire E Landry D Levesque C Rouillard 2003 Denervation and repeated L-DOPA induce a coordinate expression of the transcription factor NGFI-B in striatal projection pathways in hemi-parkinsonian rats Neurobiol Dis 14 98 109
37. 2O PET study in healthy volunteers. Hum Brain Mapp (in press)
38. P Vernier JF Julien P Rataboul O Fourrier C Feuerstein J Mallet 1988 Similar time course changes in striatal levels of glutamic acid decarboxylase and proenkephalin mRNA following dopaminergic deafferentation in the rat J Neurochem 51 1375 1380
39. P Voorn G Roest HJ Groenewegen 1987 Increase of enkephalin and decrease of substance P immunoreactivity in the dorsal and ventral striatum of the rat after midbrain 6-hydroxydopamine lesions Brain Res 412 391 396
40. PD Walker LA Riley RP Hart GM Jonakait 1991 Serotonin regulation of tachykinin biosynthesis in the rat neostriatum Brain Res 546 33 39
41. BY Zeng J Jolkkonen P Jenner CD Marsden 1995 Chronic L-DOPA treatment differentially regulates gene expression of glutamate decarboxylase, preproenkephalin and preprotachykinin in the striatum of 6-hydroxydopamine- lesioned rat Neuroscience 66 19 28